Nuveen’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Nuveen’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-15,471	Closed	-$827	–	1491
2016 Q1	$827	Sell	15,471 -1,316	-8%	-$97.1K	﹤0.01%	1088
2015 Q4	$1.9K	Buy	16,787 +1,078	+7%	+$119K	0.01%	793
2015 Q3	$1.85K	Sell	15,709 -1,916	-11%	-$250K	0.01%	784
2015 Q2	$1.36K	Buy	+17,625	New	+$1.16M	0.01%	1004

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Nuveen's ANAC Position: Q2 2016 in Review

Nuveen sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 15,471 shares — an estimated $827 sold.

Nuveen first reported a position in ANAC in Q2 2015 and held it in 4 quarters. The position peaked at $1.9K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Nuveen reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Nuveen sold 15,471 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $827.
Nuveen first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 4 quarters.
Nuveen's ANACOR PHARMACEUTICALS INC COM position peaked at $1.9K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Nuveen's 13F filing for Q2 2016, filed 12 Aug 2016.